These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11082986)
21. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin. Winkler MS; Larena-Avellaneda A; Diener H; Kölbel T; Debus ES J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):183-92. PubMed ID: 23443603 [TBL] [Abstract][Full Text] [Related]
22. [Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome]. Boda Z; Schlammadinger A; László P; Lakos G; Kerényi A; Pfliegler G; Rázsó K; Pósán E Orv Hetil; 2003 Jun; 144(23):1131-4. PubMed ID: 12858645 [TBL] [Abstract][Full Text] [Related]
23. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. Geerts WH; Jay RM; Code KI; Chen E; Szalai JP; Saibil EA; Hamilton PA N Engl J Med; 1996 Sep; 335(10):701-7. PubMed ID: 8703169 [TBL] [Abstract][Full Text] [Related]
24. [Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study]. Habscheid W; Spannagel U; Kujath P; Schindler G Vasa Suppl; 1991; 33():222-3. PubMed ID: 1664978 [TBL] [Abstract][Full Text] [Related]
25. Prevention of thrombosis during pregnancy. Vilela VS; de Jesús NR; Levy RA Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343 [No Abstract] [Full Text] [Related]
26. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
28. Deep-vein thrombosis in pregnancy. A case report. du Toit DF; McCormich M; Laker L S Afr Med J; 1985 May; 67(19):781-2. PubMed ID: 3992408 [TBL] [Abstract][Full Text] [Related]
29. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. Colwell CW; Froimson MI; Mont MA; Ritter MA; Trousdale RT; Buehler KC; Spitzer A; Donaldson TK; Padgett DE J Bone Joint Surg Am; 2010 Mar; 92(3):527-35. PubMed ID: 20194309 [TBL] [Abstract][Full Text] [Related]
30. Prevention and management of venous thromboembolism in pregnancy. James AH Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457 [TBL] [Abstract][Full Text] [Related]
31. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303 [TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin. Andersen AS; Berthelsen JG; Bergholt T Acta Obstet Gynecol Scand; 2010; 89(1):15-21. PubMed ID: 19916891 [TBL] [Abstract][Full Text] [Related]
33. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Subcutaneous heparin is as good as low-molecular-weight heparin in the acute treatment of thrombo-embolic disease. Munro A; English C Emerg Med J; 2008 May; 25(5):287-9. PubMed ID: 18434466 [No Abstract] [Full Text] [Related]
34. [CBO guideline 'Deep venous thrombosis and pulmonary embolism; revision of the earlier guidelines. Dutch Organization for Quality Assurance in Hospitals]. Büller HR; van der Meer J; Oudkerk M Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1531-7. PubMed ID: 10949636 [TBL] [Abstract][Full Text] [Related]
35. A randomised open-label trial comparing long-term sub-cutaneous low-molecular-weight heparin compared with oral-anticoagulant therapy in the treatment of deep venous thrombosis. Romera A; Cairols MA; Vila-Coll R; Martí X; Colomé E; Bonell A; Lapiedra O Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):349-56. PubMed ID: 19121589 [TBL] [Abstract][Full Text] [Related]
36. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Kleindienst A; Harvey HB; Mater E; Bronst J; Flack J; Herenz K; Haupt WF; Schön R Acta Neurochir (Wien); 2003 Dec; 145(12):1085-90; discussion 1090-1. PubMed ID: 14663565 [TBL] [Abstract][Full Text] [Related]
37. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group. Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214 [TBL] [Abstract][Full Text] [Related]
38. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of low molecular weight heparin in renal transplantation. Alkhunaizi AM; Olyaei AJ; Barry JM; deMattos AM; Conlin MJ; Lemmers MJ; Bennett WM; Norman DJ Transplantation; 1998 Aug; 66(4):533-4. PubMed ID: 9734500 [TBL] [Abstract][Full Text] [Related]
40. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]